Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoid Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00151736
What this trial is testing

Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Cephalon 88
Not applicableStudy completedNCT00602134
What this trial is testing

Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions

Who this might be right for
Acute Lymphoblastic Leukemia
Roxane Laboratories 54
Not applicableStudy completedNCT00899652
What this trial is testing

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 149
Testing effectiveness (Phase 2)Study completedNCT00349349
What this trial is testing

HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab

Who this might be right for
Leukaemia, Lymphocytic, Chronic
GlaxoSmithKline 223
Early research (Phase 1)Study completedNCT00003289
What this trial is testing

UCN-01 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)UnknownNCT04731974
What this trial is testing

Acute Concussion and Melatonin

Who this might be right for
Concussion, MildConcussion, BrainPediatric ALL
Children's National Research Institute 254
Large-scale testing (Phase 3)Study completedNCT00430118
What this trial is testing

Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
University Hospital Schleswig-Holstein 4,559
Not applicableStudy completedNCT05190952
What this trial is testing

Dexamethasone & Ketamine as Adjuvants to Bupivacaine for Incisional Infiltration in Pediatric Abdominal Operations

Who this might be right for
Pediatric ALL
Ain Shams University 150
Large-scale testing (Phase 3)UnknownNCT03553238
What this trial is testing

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Who this might be right for
Leukemia, AcuteLeukemia, T CellLeukemia, Lymphoblastic
Nanfang Hospital, Southern Medical University 70
Large-scale testing (Phase 3)Study completedNCT01556776
What this trial is testing

Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 89
Testing effectiveness (Phase 2)Looking for participantsNCT06530550
What this trial is testing

PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 51
Post-approval studies (Phase 4)Study completedNCT00198991
What this trial is testing

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Who this might be right for
Adult Acute Lymphocytic Leukemia
Goethe University 1,883
Testing effectiveness (Phase 2)Study completedNCT02362035
What this trial is testing

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Who this might be right for
Follicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more
Acerta Pharma BV 161
Not applicableLooking for participantsNCT06299540
What this trial is testing

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Cilag S.A.S. 180
Not applicableStudy completedNCT04858568
What this trial is testing

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Who this might be right for
Classical Hodgkin LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal B Cell Lymphoma+10 more
University Hospital Southampton NHS Foundation Trust 592
Not applicableLooking for participantsNCT07813208
What this trial is testing

Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
The Children's Hospital of Zhejiang University School of Medicine 500
Not applicableEnded earlyNCT00594308
What this trial is testing

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Indiana University 10
Testing effectiveness (Phase 2)UnknownNCT02846584
What this trial is testing

A Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLeukemia, Lymphocytic, Chronic, B-CellLymphoma，Malignant
Southwest Hospital, China 100
Testing effectiveness (Phase 2)Study completedNCT00440726
What this trial is testing

Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 31
Testing effectiveness (Phase 2)Study completedNCT01000285
What this trial is testing

EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma

Who this might be right for
Leukemia-Lymphoma, Adult T-Cell
Washington University School of Medicine 18
Next Page